Scientists are hoping to prove that type 1 diabetes can be reversed with the help of a generic drug. The five-year long, phase II clinical trial, which received approval from the U.S. Food and Drug Administration, was recently announced. Denise Faustman, associate professor of medicine at Massachusetts General Hospital, is principal investigator of the study.
Trending News
Children Are Left Out of Medical AI. A New Method Could Help.
Adult radiology models can be adapted for newborns without data leaving hospitals
First Large-Scale Study Shows How Doctors Use AI in Medicine
Which practitioners use artificial intelligence in the clinic, and what do they ask?
Patient Who Received Pig Kidney Becomes First To Progress to Human Kidney Transplant
Study shows xenotransplantation can serve as a bridge for patients with end-stage kidney disease